678
Participants
Start Date
May 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Linagliptin
tablet
Boehringer Ingelheim Investigational Site 43, Agoo, La Union
Boehringer Ingelheim Investigational Site 40, Angeles City, Pampanga
Boehringer Ingelheim Investigational Site 31, Angono, Rizal
Boehringer Ingelheim Investigational Site 32, Antipolo, Rizal
Boehringer Ingelheim Investigational Site 27, Aparri, Cagayan
Boehringer Ingelheim Investigational Site 4, Batangas
Boehringer Ingelheim Investigational Site 48, Butuan City, Agusan Del Norte
Boehringer Ingelheim Investigational Site 12, Cabanatuan, Nueva Ecija
Boehringer Ingelheim Investigational Site 23, Cagayan de Oro
Boehringer Ingelheim Investigational Site 3, Caloocan
Boehringer Ingelheim Investigational Site 42, Cardona, Rizal
Boehringer Ingelheim Investigational Site 25, Cebu
Boehringer Ingelheim Investigational Site 44, Dagupan, Pangasinan
Boehringer Ingelheim Investigational Site 49, Iligan City, Lanao Del Norte
Boehringer Ingelheim Investigational Site 2, Iloilo City
Boehringer Ingelheim Investigational Site 45, Iriga City, Camarines Sur
Boehringer Ingelheim Investigational Site 20, Laoag, Ilocos Norte
Boehringer Ingelheim Investigational Site 24, Las Piñas
Boehringer Ingelheim Investigational Site 7, Legazpi, Albay
Boehringer Ingelheim Investigational Site 35, Lucena, Quezon
Boehringer Ingelheim Investigational Site 1, Makati
Boehringer Ingelheim Investigational Site 39, Malolos, Bulacan
Boehringer Ingelheim Investigational Site 37, Mandaluyong
Boehringer Ingelheim Investigational Site 28, Manila
Boehringer Ingelheim Investigational Site 5, Marikina City
Boehringer Ingelheim Investigational Site 16, Meycauyan, Bulacan
Boehringer Ingelheim Investigational Site 47, Naga City, Camarines Sur
Boehringer Ingelheim Investigational Site 15, Olongapo City
Boehringer Ingelheim Investigational Site 10, Pampanga
Boehringer Ingelheim Investigational Site 19, Paranaque City
Boehringer Ingelheim Investigational Site 51, Pasay
Boehringer Ingelheim Investigational Site 30, Pasig
Boehringer Ingelheim Investigational Site 34, Puerto Princesa, Palawan
Boehringer Ingelheim Investigational Site 26, Quezon City
Boehringer Ingelheim Investigational Site 11, Rosales, Pangasinan
Boehringer Ingelheim Investigational Site 21, San Fernando, La Union
Boehringer Ingelheim Investigational Site 9, San Fernando, Pampanga
Boehringer Ingelheim Investigational Site 13, San Jose, Nueva Ecija
Boehringer Ingelheim Investigational Site 29, San Juan City
Boehringer Ingelheim Investigational Site 8, San Pablo, Laguna
Boehringer Ingelheim Investigational Site 50, San Pedro, Laguna
Boehringer Ingelheim Investigational Site 41, Santiago City, Isabela
Boehringer Ingelheim Investigational Site 36, Sogod, Southern Leyte
Boehringer Ingelheim Investigational Site 38, Sta.Maria, Bulacan
Boehringer Ingelheim Investigational Site 6, Tacloban City
Boehringer Ingelheim Investigational Site 33, Tagbilaran, Bohol
Boehringer Ingelheim Investigational Site 14, Tuguegarao, Cagayan
Boehringer Ingelheim Investigational Site 18, Urdaneta, Pangasinan
Boehringer Ingelheim Investigational Site 46, Valencia City Bukidnon
Boehringer Ingelheim Investigational Site 17, Valenzuela, Bulacan
Boehringer Ingelheim Investigational Site 22, Zamboanga City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY